Intercure is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Alexander Rabinovich, with a market cap of $41.7M.
Common questions about Intercure
Intercure is scheduled to report earnings for FY 2025 on April 21, 2026 after market close.
Intercure has approximately 280 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.